CLINICAL TRIAL / NCT05790213

Prostate Cancer Treatment Using Androgen Deprivation Therapy and Focal Prostate Ablation

  • Interventional
  • Recruiting
  • NCT05790213

Contact Information

  • Anukriti Sinha

Phase II Trial of Focal Prostate Ablation Combined With Androgen Deprivation Therapy for Prostate Cancer Treatment

The purpose of this research is to gather information on the safety and effectiveness of combining focal prostate ablation therapy ((aka Focal Therapy, a surgical procedure) and androgen deprivation therapy (hormone therapy).